High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group (Q46847866)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group |
scientific article |
Statements
1 reference
High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group (English)
1 reference
1 reference
Noriko Usui
1 reference
Masamitsu Yanada
1 reference
Jin Takeuchi
1 reference
Isamu Sugiura
1 reference
Hideki Akiyama
1 reference
Fumiharu Yagasaki
1 reference
Tohru Kobayashi
1 reference
Yasunori Ueda
1 reference
Makoto Takeuchi
1 reference
Shuichi Miyawaki
1 reference
Atsuo Maruta
1 reference
Nobuhiko Emi
1 reference
Yasushi Miyazaki
1 reference
Shigeki Ohtake
1 reference
Itsuro Jinnai
1 reference
Tomoki Naoe
1 reference
Ryuzo Ohno
1 reference
Japan Adult Leukemia Study Group
1 reference
12 December 2005
1 reference
24
1 reference
3
1 reference
460-466
1 reference
Identifiers
1 reference